Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/09/2003US20030191062 Bone marrow specific protein
10/09/2003US20030191061 Viricides; therapy for infections; anticancer agents; antidiabetic agents; administering cyclin by mouth; applying radio frequency signals
10/09/2003US20030191060 Respiratory system disorders; cardiovascular disorders; controlling signal transduction
10/09/2003US20030191059 Antitumor agents; anticancer agents; wound healing agents; cardiovascular disorders
10/09/2003US20030191058 Anticancer agents; antiinflammatory agents
10/09/2003US20030191057 Cardiovascular disorders; antiinflammatory agents
10/09/2003US20030191056 Immobilization onto polyoxyethylene glycol
10/09/2003US20030191055 Inhibiting development of microvessels withins coronary or peripheral vessel walls for restenosis/atherosclerosis prevention or therapy
10/09/2003US20030191054 Novel bag proteins and nucleic acid molecules encoding them
10/09/2003US20030191053 Cyclic peptide derivative
10/09/2003US20030191052 Infection therapy; binding of mannan lecithin to protein
10/09/2003US20030191051 Combination therapy for the treatment of bacterial infections
10/09/2003US20030191050 Method and apparatus for preparing an acellular read blood cell substitute
10/09/2003US20030191048 Gene expression profile for KSHV infection and methods for treating same
10/09/2003US20030190740 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment
10/09/2003US20030190739 Tankyrase2 materials and methods
10/09/2003US20030190737 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
10/09/2003US20030190735 Oncoprotein protein kinase
10/09/2003US20030190732 Plasma fraction containing bikunin, method for the production thereof and use of the same
10/09/2003US20030190731 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190730 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190729 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190728 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190727 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190726 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190725 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190724 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190722 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190721 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190720 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190719 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190718 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190717 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190716 Used to produce pharmaceuticals, diagnostics, biosensors, bioreactors; PRO polypeptides
10/09/2003US20030190709 Modulation apoptosis; Alzheimer's diseases; Parkinson's disease; amyotropic lateral sclerosis
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190702 Used to treat human malignancies associated with heregulin-mediated cell growth such as breast and prostate cancer
10/09/2003US20030190701 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190698 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190697 With advantages such as ability of the polypeptides to preferentially bind a CD28/CTLA-4 receptor at a level greater or less than the ability of human B7-1, inhibit altered level of T cell proliferation response greater than human B7-1
10/09/2003US20030190696 Vertebrate tissue pattern-inducing proteins, and uses related thereto
10/09/2003US20030190680 Photocleavable bioreactive agents
10/09/2003US20030190679 Used to treat apoptotic disorder like cancer, autoimmune disorder, viral infections, Alzheimer's disease, Parkinson's disease or aplastic anemia; treats inflammatory disorders like arthritis, Crohn's disease, psoriasis, allergy or asthma
10/09/2003US20030190677 Obtaining a consensus protein from a group of amino acid sequences of a defined protein family
10/09/2003US20030190669 Humanized antibody.
10/09/2003US20030190668 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190667 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190659 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases
10/09/2003US20030190654 Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene
10/09/2003US20030190651 Preventing, ameliorating, correcting dysfunctions or diseases such as cancer, peripheral and central nervous system diseases, and chronic obstructive pulmonary disease
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190638 Determination of telomere length and telomerase activity, ability to increase/decrease the activity in treatment of proliferative diseases; intracellular inhibition of telomerase activity; treatment of cancer and AIDS, muscular dystrophy
10/09/2003US20030190637 Mutations in spink5 responsible for netherton's syndrome and atopic diseases
10/09/2003US20030190635 RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
10/09/2003US20030190629 Antisense modulation of PTTG1 expression
10/09/2003US20030190626 Having increased nuclease resistance and binding affinity to a complementary strand of nucleic acid; useful for modulating expression of a protein in organisms, for diagnosis, therapy of conditions responsive to oligonucleotide therapeutics
10/09/2003US20030190625 For prognosis, diagnosis, monitering, drug discovery, therapy, clinical medicine, forensic science, predisposition determination; kidins is upregulated in prostate cancer
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190611 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190610 Proteins involved in differentiation, maintenance of multicellular organisms, e.g. proliferation, migration, interaction of cells through drugs
10/09/2003US20030190606 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
10/09/2003US20030190600 Used in treatments for bacterial infections, dysentery, angiogenesis, immune cell mediated disease
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190357 Compositions for delivery of a cortisol antagonist
10/09/2003US20030190342 Administering to the vascular tissue a therapeutically effective amount of Saratin polypeptide to prevent platelet adhesion, so inhibiting thrombosis and restenosis
10/09/2003US20030190329 Coxsackievirus vectors and their use in prevention and treatment of disease
10/09/2003US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
10/09/2003US20030190327 Seaweed extract (from red macroalgae); storage stability
10/09/2003US20030190324 Immunologically significant herpes simplex virus antigens and methods for using same
10/09/2003US20030190323 Preparations and methods for the treatment of T cell mediated diseases
10/09/2003US20030190318 Immunosuppressants for treatment of autoimmune and allergic diseases; cytokines
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
10/09/2003US20030190310 Primary package containing a low molecular weight peptide-based thrombin inhibitors sealed with a bromobutyl rubber stopper or plunger
10/09/2003US20030190307 Stable liquid interferon formulations
10/09/2003US20030190305 Administering to subject a therapeutically effective amount of IL-12 or a biologically active fragment or subunit thereof
10/09/2003US20030190304 Pegylation reagents and compounds formed therewith
10/09/2003US20030190303 For treating allergic disorders characterized by a local immune response including inflammatory skin reactions, asthma, and arthritis
10/09/2003US20030190291 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
10/09/2003US20030190286 Propellant free buccal spray composition for transmucosal administration of pharmacologically active compound comprising 0.001-60 percent by weight immunosuppressants, mucolytics, glucocorticoids and 30-99 percent polar solvent
10/09/2003US20030190285 Having nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof; diagnostic and therapeutic applications
10/09/2003US20030190284 Agglomerated particles for aerosol drug delivery
10/09/2003CA2519642A1 A composition and method for killing of tumours
10/09/2003CA2481376A1 Novel proteins and nucleic acids encoding same
10/09/2003CA2481315A1 Lactoferrin
10/09/2003CA2481304A1 Method for treating cancer in humans
10/09/2003CA2481269A1 Taste masked compositions of erythromycin a and derivatives thereof
10/09/2003CA2481253A1 Vegf peptides and their use
10/09/2003CA2481232A1 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003CA2481221A1 Use of angiotensin 1-7 for enhancing cardiac function
10/09/2003CA2481214A1 Viscous preparation for dental use containing basic fibroblast growth factor
10/09/2003CA2480904A1 Prothrombin activating protein
10/09/2003CA2480694A1 Ox40r binding agents
10/09/2003CA2480661A1 A method of modulating cellular activity
10/09/2003CA2480656A1 Bioadhesive directed somatic cell therapy
10/09/2003CA2480635A1 Cancer associated protein kinases and their uses
10/09/2003CA2480634A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
1 ... 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 ... 3163